In this study we apply computational protein design protocols to design macrocyclic peptoid–peptide hybrids to target the N-terminal TCF β-hairpin binding pocket of β-catenin and demonstrate its potential for use as a therapeutic in prostate cancer models. Here, HNF4A is linked to prostate cancer.